Approval · Notice of Compliance 18195 · 2016
EMPLICITI: Notice of Compliance 18195
Issued June 21, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 18195
- Date
- June 21, 2016
- Company
- Bristol-Myers Squibb CanadaSt-Laurent, Quebec, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
Products in this notice
Medicinal ingredients
- ELOTUZUMAB 300 MG per VIAL
- ELOTUZUMAB 400 MG per VIAL